(Reuters) - Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less ...

Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

TRENTON, N.J. (AP) — Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October about an extensive recall of thousands of bottles of atorvastatin, the generic ...

Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...

During the first full week that generic Lipitor was available, the brand-name version accounted for less than half of the prescriptions for the... It's here. The cholesterol-fighter Liptor, the ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the ...

High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...

TORONTO/NEW YORK (Reuters) - Apotex Inc said on Wednesday it would immediately launch in Canada a copycat form of Pfizer Inc's blockbuster Lipitor cholesterol fighter, and Pfizer vowed to fight back ...

Sales of the blockbuster cholesterol fighter Lipitor plunged by half barely a week after the world's top-selling drug got its first generic competition in the U.S., new data show. That's despite an ...